Literature DB >> 18492803

Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice.

Koji Yamanaka1, Severine Boillee, Elizabeth A Roberts, Michael L Garcia, Melissa McAlonis-Downes, Oliver R Mikse, Don W Cleveland, Lawrence S B Goldstein.   

Abstract

Dominant mutations in ubiquitously expressed superoxide dismutase (SOD1) cause familial ALS by provoking premature death of adult motor neurons. To test whether mutant damage to cell types beyond motor neurons is required for the onset of motor neuron disease, we generated chimeric mice in which all motor neurons and oligodendrocytes expressed mutant SOD1 at a level sufficient to cause fatal, early-onset motor neuron disease when expressed ubiquitously, but did so in a cellular environment containing variable numbers of non-mutant, non-motor neurons. Despite high-level mutant expression within 100% of motor neurons and oligodendrocytes, in most of these chimeras, the presence of WT non-motor neurons substantially delayed onset of motor neuron degeneration, increasing disease-free life by 50%. Disease onset is therefore non-cell autonomous, and mutant SOD1 damage within cell types other than motor neurons and oligodendrocytes is a central contributor to initiation of motor neuron degeneration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18492803      PMCID: PMC2396671          DOI: 10.1073/pnas.0802556105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection.

Authors:  Q Richard Lu; Tao Sun; Zhimin Zhu; Nan Ma; Meritxell Garcia; Charles D Stiles; David H Rowitch
Journal:  Cell       Date:  2002-04-05       Impact factor: 41.582

2.  Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice.

Authors:  A M Clement; M D Nguyen; E A Roberts; M L Garcia; S Boillée; M Rule; A P McMahon; W Doucette; D Siwek; R J Ferrante; R H Brown; J-P Julien; L S B Goldstein; D W Cleveland
Journal:  Science       Date:  2003-10-03       Impact factor: 47.728

3.  ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions.

Authors:  L I Bruijn; M W Becher; M K Lee; K L Anderson; N A Jenkins; N G Copeland; S S Sisodia; J D Rothstein; D R Borchelt; D L Price; D W Cleveland
Journal:  Neuron       Date:  1997-02       Impact factor: 17.173

4.  An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria.

Authors:  P C Wong; C A Pardo; D R Borchelt; M K Lee; N G Copeland; N A Jenkins; S S Sisodia; D W Cleveland; D L Price
Journal:  Neuron       Date:  1995-06       Impact factor: 17.173

5.  Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons.

Authors:  T L Williamson; D W Cleveland
Journal:  Nat Neurosci       Date:  1999-01       Impact factor: 24.884

6.  VAChT-Cre. Fast and VAChT-Cre.Slow: postnatal expression of Cre recombinase in somatomotor neurons with different onset.

Authors:  Hidemi Misawa; Kazuko Nakata; Kyoko Toda; Junko Matsuura; Yoshio Oda; Haruhisa Inoue; Minako Tateno; Ryosuke Takahashi
Journal:  Genesis       Date:  2003-09       Impact factor: 2.487

7.  Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease.

Authors:  Maria Maddalena Lino; Corinna Schneider; Pico Caroni
Journal:  J Neurosci       Date:  2002-06-15       Impact factor: 6.167

Review 8.  Unraveling the mechanisms involved in motor neuron degeneration in ALS.

Authors:  Lucie I Bruijn; Timothy M Miller; Don W Cleveland
Journal:  Annu Rev Neurosci       Date:  2004       Impact factor: 12.449

9.  Superoxide dismutase is an abundant component in cell bodies, dendrites, and axons of motor neurons and in a subset of other neurons.

Authors:  C A Pardo; Z Xu; D R Borchelt; D L Price; S S Sisodia; D W Cleveland
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-14       Impact factor: 11.205

10.  Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model.

Authors:  Brian K Kaspar; Jerònia Lladó; Nushin Sherkat; Jeffrey D Rothstein; Fred H Gage
Journal:  Science       Date:  2003-08-08       Impact factor: 47.728

View more
  123 in total

1.  Suppression of the novel ER protein Maxer by mutant ataxin-1 in Bergman glia contributes to non-cell-autonomous toxicity.

Authors:  Hiroki Shiwaku; Natsue Yoshimura; Takuya Tamura; Masaki Sone; Soichi Ogishima; Kei Watase; Kazuhiko Tagawa; Hitoshi Okazawa
Journal:  EMBO J       Date:  2010-06-08       Impact factor: 11.598

2.  ALS-linked mutant superoxide dismutase 1 (SOD1) alters mitochondrial protein composition and decreases protein import.

Authors:  Quan Li; Christine Vande Velde; Adrian Israelson; Jing Xie; Aaron O Bailey; Meng-Qui Dong; Seung-Joo Chun; Tamal Roy; Leah Winer; John R Yates; Roderick A Capaldi; Don W Cleveland; Timothy M Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-15       Impact factor: 11.205

Review 3.  Stem cell-derived motor neurons: applications and challenges in amyotrophic lateral sclerosis.

Authors:  Jason R Thonhoff; Luis Ojeda; Ping Wu
Journal:  Curr Stem Cell Res Ther       Date:  2009-09       Impact factor: 3.828

Review 4.  Glial cells in amyotrophic lateral sclerosis.

Authors:  T Philips; J D Rothstein
Journal:  Exp Neurol       Date:  2014-05-22       Impact factor: 5.330

5.  Metalloproteinase alterations in the bone marrow of ALS patients.

Authors:  Patrizia Bossolasco; Lidia Cova; Cinzia Calzarossa; Federica Servida; Niccolò Emanuele Mencacci; Francesco Onida; Elio Polli; Giorgio Lambertenghi Deliliers; Vincenzo Silani
Journal:  J Mol Med (Berl)       Date:  2010-01-21       Impact factor: 4.599

6.  Mutant SOD1 G93A microglia have an inflammatory phenotype and elevated production of MCP-1.

Authors:  Siranush A Sargsyan; Daniel J Blackburn; Siân C Barber; Peter N Monk; Pamela J Shaw
Journal:  Neuroreport       Date:  2009-10-28       Impact factor: 1.837

Review 7.  Inflammation in ALS and SMA: sorting out the good from the evil.

Authors:  Dimitra Papadimitriou; Virginia Le Verche; Arnaud Jacquier; Burcin Ikiz; Serge Przedborski; Diane B Re
Journal:  Neurobiol Dis       Date:  2009-10-13       Impact factor: 5.996

Review 8.  Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia.

Authors:  Deepti Lall; Robert H Baloh
Journal:  J Clin Invest       Date:  2017-07-24       Impact factor: 14.808

9.  Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology.

Authors:  Nurit Ballas; Daniel T Lioy; Christopher Grunseich; Gail Mandel
Journal:  Nat Neurosci       Date:  2009-02-22       Impact factor: 24.884

10.  Experimental models for the study of neurodegeneration in amyotrophic lateral sclerosis.

Authors:  Luis B Tovar-Y-Romo; Luz Diana Santa-Cruz; Ricardo Tapia
Journal:  Mol Neurodegener       Date:  2009-07-20       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.